Biocon announces merger of its arm with Serum Institute subsidiary

The company stated that there is no cash consideration involved but BBL will issue and allot 15 per cent equity shares to Serum on a fully diluted basis, subject to necessary approvals and sanctions.

Related Keywords

India ,Pune ,Maharashtra ,Adar Poonawalla ,Biocon Biologics Ltd ,Biocon Limited On ,Biocon ,Serum Institute Life Sciences Private ,Covidshield Technologies Pvt Ltd ,Serum Institute Of India ,Biocon Limited ,Serum Institute ,Serum Institute Life Sciences Private Limited ,Biocon Biologics ,Bl ,Iocon Subsidiary ,Erum Subsidiary ,Iocon Serum Subsidiaries Merger ,